The latest announcement is out from FibroBiologics, Inc. (FBLG).
FibroBiologics, Inc. sold 100,000 shares to GEM at $4.51 each, after a 10% discount, totaling $451,000 in proceeds. This followed a previous transaction where 3 million shares facilitated a draw down, with GEM accepting 840,000 of these at $4.09 per share, providing FibroBiologics with $3.44 million in proceeds. The unutilized 1.5 million shares from the draw down notice will be returned and cancelled, with the Company having received a total of $3.89 million from its sales under the share purchase agreement with GEM.
For an in-depth examination of FBLG stock, go to TipRanks’ Stock Analysis page.
